Whether you’re a new runner or an experienced one, the stride length you naturally choose is likely your most efficient, ...

Unlock an exclusive sect shop, along with marrying benefits, by joining the Velvet Shade sect in Where Winds Meet.

To access the SIR form, voters must log in via the Voters’ Service Portal (voters.eci.gov.in) and select the “Fill Enumeration Form” option. As the Election Commission of India carries out the second ...

Vertex Pharmaceuticals recently presented updated interim data at the 2025 ASN Kidney Week, revealing significant proteinuria reductions and eGFR stabilization with povetacicept in patients with IgA ...

Robots may not be taking the place of researchers in lab coats running clinical trials anytime soon, but AI is playing an increasingly important role in drug discovery efforts. That’s the message ...

During Vertex’s third-quarter presentation, Chief Commercial Officer Duncan McKechnie cited several numbers that suggest the launch of its long-awaited, non-opioid pain reliever Journavx is trending ...

Ed Silverman, a senior writer and Pharmalot columnist at STAT, has been covering the pharmaceutical industry for nearly three decades. He is also the author of the morning Pharmalittle newsletter and ...

Vertex Pharmaceuticals plans by year-end to submit part of a license application to regulators for its kidney-disease treatment, and to have the full application submitted by first half of next year.

Louis Tomlinson has announced a 2026 North American tour in support of his upcoming third solo album, “How Did I Get Here?,” set for release on January 23. The former One Direction member will embark ...

For the fastest way to join Tom's Guide Club enter your email below. We'll send you a confirmation and sign you up to our newsletter to keep you updated on all the latest news. By submitting your ...

This year’s premier football game from EA, EA FC 26, promises to bring major upgrades to so much of what players engage with the most, not to mention evolve decades-long features and modes to bring ...

Vertex Pharmaceuticals is offering Enlaza Therapeutics more than $2 billion in biobucks through a multitarget drug discovery deal aiming to create new T-cell engagers and small-format drug conjugates.